Re-biopsy after relapse of targeted therapy. T790M after epidermal growth factor mutation, where and why based on a case series

Guidelines for the treatment of non-small cell lung cancer adenocarcinoma positive in epidermal growth factor mutations indicate tyrosine kinase inhibitors. There are currently three tyrosine kinase inhibitors that can be used as first line treatment: gefitinib, erlotinib and afatinib. Regarding erl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarogoulidis, Paul, Rapti, Aggeliki, Sardeli, Chrysanthi, Chinelis, Panagiotis, Athanasiadou, Anastasia, Paraskevaidou, Katerina, Kallianos, Anastasios, Veletza, Lemonia, Trakada, Georgia, Hohenforst-Schmidt, Wolfgang, Huang, Haidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458763/
https://www.ncbi.nlm.nih.gov/pubmed/28616379
http://dx.doi.org/10.1016/j.rmcr.2017.05.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458763/
https://www.ncbi.nlm.nih.gov/pubmed/28616379
http://dx.doi.org/10.1016/j.rmcr.2017.05.013

Ejemplares similares